BEAM

#1454
Beam Therapeutics Inc. Common Stock
28.46
-1.11%
Setor:
Base:
Moeda do lucro:
Faixa diária
28.46
28.46
Faixa anual
13.52
36.44
Mudança diária
-1.11%
Mudança mensal
-8.07%
Mudança em 6 meses
+67.41%
Mudança anual
+6.31%
Fechamento anterior
28.78
Open
28.46
Bid
Ask
Low
28.46
High
28.46
Volume
220
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Beam Therapeutics Inc

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Notícias